Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study

Shervin Taslimi1, Hamed Vahidi, Ali Pourvaziri

  • 1Otorhinolaryngology Research Center, Tehran University of Medical Sciences, Tehran, Iran. taslimi@razi.tums.ac.ir

Summary

Ondansetron significantly reduced tinnitus severity in patients, improving the Tinnitus Severity Index (TSI) score. This medication also enhanced speech recognition and pure tone audiometry, suggesting a potential cochlear amplification effect for tinnitus management.